Multicenter prospective observational study on metastatic hormone-naive prostate cancer

Multicenter prospective observational study on metastatic hormone-naive prostate cancer - Multicenter prospective observational study on metastatic hormone-naive prostate cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044649

Enrollment

400

Registered

2021-06-24

Start date

2021-04-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic hormone-naive prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Metastatic hormone naive prostate cancer

Exclusion criteria

Exclusion criteria: Patients for whom it is impossible to obtain consent

Design outcomes

Primary

Measure	Time frame
Clinical practice and outcomes of metastatic hormone-naive prostate cancer	—

Countries

Japan

Contacts

Public ContactSoichiro Yoshida

Tokyo Medical and Dental University Urology

ikyouro@tmd.ac.jp03-5803-5295

Outcome results